TW504385B - Composition for relieving physical and mental fatigue and ameliorating weakened constitution - Google Patents
Composition for relieving physical and mental fatigue and ameliorating weakened constitution Download PDFInfo
- Publication number
- TW504385B TW504385B TW085115773A TW85115773A TW504385B TW 504385 B TW504385 B TW 504385B TW 085115773 A TW085115773 A TW 085115773A TW 85115773 A TW85115773 A TW 85115773A TW 504385 B TW504385 B TW 504385B
- Authority
- TW
- Taiwan
- Prior art keywords
- weight
- natural medicine
- composition
- natural
- muirapuama
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 208000019914 Mental Fatigue Diseases 0.000 title claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- 241000340987 Ptychopetalum olacoides Species 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims description 17
- 238000011049 filling Methods 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000469 ethanolic extract Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 description 82
- 239000007788 liquid Substances 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 23
- -1 vitamins Bp B2 Natural products 0.000 description 15
- 229940079593 drug Drugs 0.000 description 11
- 230000002079 cooperative effect Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 8
- 239000000123 paper Substances 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 240000004371 Panax ginseng Species 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 210000003056 antler Anatomy 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 241000405414 Rehmannia Species 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000013736 caramel Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 229920001342 Bakelite® Polymers 0.000 description 2
- 240000008564 Boehmeria nivea Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 244000080208 Canella winterana Species 0.000 description 2
- 235000008499 Canella winterana Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 241001289529 Fallopia multiflora Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000004637 bakelite Substances 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 229940017545 cinnamon bark Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000000569 greater omentum Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940089133 vitamin b6 5 mg Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- YTCJPMWRBDVDMB-ZQMQSLPDSA-N (1S,3R,4S,6R,7S,9R,10R,11R,12S,14R,16R,17S,19R,21R,22S,24R,26R,27S,29R,31R,32S,34R,36R,37S,39R,41R,42S,44R,46R,47S,49R,51R,52S,54R,56R,57S,59R,61R,62S,64R,65R,66R,67R,69R,70R,71R,72R,73R,74R,75R,76R,77R,78R,79R,80R,81R,82R,83R,84R,85R,86R,87R,88R,89R,91S)-6,16,21,26,31,36,41,46,51,56,61,67,89-tridecakis(hydroxymethyl)-2,5,8,13,15,18,20,23,25,28,30,33,35,38,40,43,45,48,50,53,55,58,60,63,68,90-hexacosaoxatetradecacyclo[62.2.2.29,12.214,17.219,22.224,27.229,32.234,37.239,42.244,47.249,52.254,57.259,62.13,7]hennonacontane-4,10,11,65,66,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,91-hexacosol Chemical compound OC[C@H]1O[C@H](O)[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@@H]9[C@@H](CO)O[C@H](O[C@@H]%10[C@@H](CO)O[C@H](O[C@@H]%11[C@@H](CO)O[C@H](O[C@@H]%12[C@@H](CO)O[C@H](O[C@@H]%13[C@@H](CO)O[C@H](O[C@@H]%14[C@@H](CO)O[C@H](O[C@H]1[C@@H]2O)[C@H](O)[C@H]%14O)[C@H](O)[C@H]%13O)[C@H](O)[C@H]%12O)[C@H](O)[C@H]%11O)[C@H](O)[C@H]%10O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O YTCJPMWRBDVDMB-ZQMQSLPDSA-N 0.000 description 1
- ALBAONCGXKQWRY-UHFFFAOYSA-N (2-butylphenoxy)methanol Chemical compound CCCCC1=CC=CC=C1OCO ALBAONCGXKQWRY-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-IANNHFEVSA-N D-sorbose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-IANNHFEVSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 235000009134 Myrica cerifera Nutrition 0.000 description 1
- 241000221014 Olacaceae Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229960000678 carnitine chloride Drugs 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940046664 taurine 500 mg Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000019966 white bee wax Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000019967 yellow bee wax Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
504385 A7 B7 五、發明説明(1 ) 本發明關於一種用於舒減生理及精神疲勞的組成物, 並且特別是關於一種用於舒減生理及精神疲勞、壓力等, 且改善或恢復虛弱身驅的組成物。此組成物係由沐若普( muirapuama)和植物蠕蟲所組成。 沐若普(Muirapuama)是一*種天然藥物,長久以來居 住在亞馬遜河盆地的人們就拿它做爲強壯劑或補藥。植物 蠕蟲也是一種天然藥物,長久以來居住在中國的人們拿它 做爲鎮靜劑或止咳劑。 單獨服用含有沐若普(Muirapuama)萃或植物懦蟲萃 的組成物,已知可有效改善身驅健康狀況,但含有沐若普 (muirapuama)和植物蠕蟲二者的組成物則尙未發表。 本發明的目標是提供一種組成物。它係藉由植物蠕蟲 強化沐若普(muirapuama)降低因壓力等引起的生理體力 或精力疲勞的效果,並且具有舒減壓力和生理疲勞和改善 或恢復虛弱身驅的效果。本組成物即使長時間服用也不會 產生任何副作用。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 經過廣泛研究,本發明者發現了 一種由沐若普(mu i -rapuama)和植物蠕蟲構成的新型組成物,它具有協同作 用舒減因壓力引起的生理和精神疲勞及改善虛弱身驅的效 果。其中沐若普(muirapuama)可有效使因各種外在和內 在因子造成身體不平衡而產生的壓力恢復成常態,植物蠕 蟲可有效促進代謝作用和舒減生理及精神疲勞如疲勞、睏 乏、膨脹的感覺等。 根據本發明,我們係提供一種用於舒減生理和精神疲 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 504385 A7 ____B7 五、發明説明(2 ) 勞及改善虛弱身驅的組成物,其中組成的沐若普(mu ira-puaraa )和植物蠕蟲是做爲有效的成份。 本發明中所使用做爲沐若普(muirapuama)的原始植 物是生長於巴西亞馬遜河盆地的鐵青樹科(〇lacaceae) 灌木,包括 Ptychopetalum olacoides,Ptychopetlum uncinatum和 Liriosma ovata,其中 Ptychopetalum olac-oides是較適宜的。不用說 ’ Ptychopetlum uncinatum和 Liriosma ovata也可使用。在本發明,我們使用這些原始 植物的根。 植物蠕蟲是氣孔’其較佳的是麥角菌科(Clavicipi -taceae)冬蟲夏草菌屬(Cordyceps)和昆蟲的幼蟲,其 中冬蟲夏草菌屬是屬於寄生性。麥角菌科內的Simizuomy-ces 屬,Podonectrioides 屬和 Torrbiella 屬也可使用。 本發明的沐若普(muirapuama)可以使用萃取物形式 ,其萃取物的製備法如下。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將細微碎片的沐若普(muirapuama)根與稀釋酒精混 合,浸漬2天並偶爾攪拌,然後將浸漬液過濾。將殘餘物 再一次與稀釋酒精混合,浸漬2天並偶爾攪拌,然後將浸 漬液過濾。把二次得到的濾液集合在一起,以減壓方式進 丫了濃縮而得到沐右普(muirapuama)萃。 本發明的植物蠕蟲可以使用萃取物形式,其萃取物的 製備法如下: 將粗碎片植物蠕蟲與稀釋酒精混合,並置於室溫2小 時,然後將此溶液與稀釋酒精混合,於室溫浸漬3天而得 I紙張尺度適用中國國家標準(CNS ) A4規格(21〇><297公餐) '' 一 5 一 經濟部中央標準局員工消費合作社印製 504385 A7 B7 五、發明説明(3) 到浸漬液。再將獲得的萃取物於室溫放置2天,以濾紙過 濾而得到液體萃取物。 根據本發明,沐若普(muirapuania)萃取的有效劑量 對於成年人來說是1 〇 — 5 0 0 Omg/天,較佳是5 0 一 1 5 (3 Omg /天;對於成年人來說植物蠕蟲液體萃取 物的有效劑量是1 0 — 5 0 0 Omg/天,較佳是5 0 -1 0 0 Omg/天。即以天然藥物量而言,每份植物蠕蟲 的液體萃取物重量加上0. 0 0 2 — 5 0 0份,宜爲 0 . 0 3 — 3 0份,最好是0 _ 5 - 8份的沐若普(mu i - rapuama )萃 0 本發明組成物可以含有咖排因、水溶液維生素如維生 素Bp B2、B6、Bi2、C、生物素、肉鹼、泛酸和菸 鹼酸和它們的衍生物,脂溶性維生素如維生素A、E和它 們的衍生物,牛磺酸、胺基酸和精胺酸和其他天然藥物, 如 agkistrodoTi 人參、紫雲英根、Polygonati root、甘草 、poria sclerotium地黃根、日本當歸根、荡枝、肉桂皮 、鹿茸角、不結果的麥芽汁、cistanchis caulis、中國 膠木膠、內風消子、e 1 e u t h e r 〇 c 〇 c c、治階草塊莖、何首 烏、牛膽汁等的萃取物或酊劑。 本發明組成物可以直接服用,或製成藥劑如口服製劑 (如:顆粒、粉末、膠囊、錠劑、乾糖漿、液體製劑等) 或注射製劑、或食品如清涼飮料或固體食品(如:餅乾) 。其製備法係將成份與其他已知的添加物,如:賦形劑、 碎解劑、黏合劑、潤滑劑、抗氧化劑、包衣劑、著色劑、 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X 297公釐) (請先閱讀背面之注意事項再填寫本頁) L% 504385 A7 ____B7 五、發明説明(4 ) 防蝕劑、界面活性劑、塑化劑、酸鹼調節劑、提神劑、懸 浮劑、消泡劑、增稠劑、助溶劑等;依照一般方法製造, 或可加至清涼飮料或食品做爲功能性成份或添加物。 根據本發明,單一沐若普(muirapuama)萃組成物和 單一植物蠕蟲萃組成物可分別包裝於分開的安瓿,當服用 時,可以將單一組成物同時混合或不必同時混合。 賦形劑包括,例如:糖醇如D -甘露醇、木糖醇和D -山梨糖醇、醣類如葡萄糖、蔗糖、乳糖和水果糖、結晶 纖維素、焦糖鈉、磷酸氫鈣、小麥澱粉、玉米澱粉、稻米 澱粉、馬鈴薯澱粉、糊精、Θ -環糊精、輕無水矽酸、氧 化鈦、間矽酸鎂鋁酸鹽等。 碎解劑包括,例如:低取代羥丙基纖維素、羧甲基纖 維鈣、羥丙基澱粉交叉焦糖鈉,部份糊化澱粉等。 黏合劑包括,例如:甲基纖維素、羥丙基纖維素、羥 丙甲基纖維素、聚乙烯吡咯酮、明膠、阿拉伯膠、乙基纖 維素、聚乙烯醇、聚三葡萄糖、糊化澱粉、洋菜、黃耆膠 、藻酸鈉、丙嫌二醇藻酸鹽等。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 潤滑劑包括,例如:硬脂酸、硬脂酸鎂、硬脂酸鈣、 聚氧硬脂酸鹽、鯨酯、滑石、氫化油、蔗糖脂肪酸酯、二 甲基聚矽氧烷、黃色蜂臘、白色蜂臘等。 抗氧化劑包括,例如:二丁羥基甲苯、五倍子酸丙酯 、丁基羥基甲氧苯、生育醇、檸檬酸等。 包衣劑包括,例如:羥丙甲基纖維素、羥丙基纖維素 、甲基纖維素、乙基纖維素、羥丙甲基纖維素酞酸鹽、羥 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -7 - 504385 A7 B7 五、發明説明(5 ) 丙甲基纖維素酯酸琥珀酸鹽、羧甲乙基纖維素、纖維素醋 酸酞酸鹽、聚乙烯縮乙醛二乙基胺醋酸鹽、甲基丙烯酸、 胺烷酯共聚合物、羥丙甲基纖維素醋酸琥珀酸鹽、甲基丙 烯酸共聚合物、聚乙烯醋酸二乙胺醋酸鹽、蟲膠等。 著色劑包括,例如:薑黃萃、核黃素、胡蘿蔔素溶液 、氧化鈦等。 界面活性劑包括,例如:聚氧乙烯氧化蓖麻油、單硬 脂酸甘油酯、單硬脂酸山梨聚糖酯、單月桂酸山梨聚糖酯 、聚氧乙烯聚氧丙烯、聚水合鹽、月桂硫酸鈉、macrogo-ls、蔗糖脂肪酸酯等。 塑化劑包括,例如:三乙基檸檬酸鹽、聚乙烯二醇、 三醋精、鯨醇等。 酸鹼調節劑包括,例如:檸檬酸、蘋果酸、磷酸氫鈉 、磷酸氫二鉀等。 *提神劑包括,例如:1 —甲醇、薄荷水等。 懸浮劑包括,例如:高嶺土、焦糖鈉、漢生膠、黃耆 膠等。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 消泡劑包括,例如:二甲基聚矽氧烷、矽酮消泡劑等 〇 增稠劑包括,例如:漢生膠、黃耆膠、甲基纖維素、 糊精等。 助溶劑包括’例如:乙醇、蔗糖脂肪酸酯、macrogol 等。 針對清涼飲料,除了上述的添加物之外,可添加其他 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇χ297公襲) -8 - 504385 A7 ____ B7 五、發明説明(6 ) 生理活性物質、礦物質、維生素、荷爾蒙、營養素、香料 等而得到特殊的口味或氣味。 本發明組成物具有預防或改善生理或精神疲勞、壓力 和虛弱身驅的效果,即使長時間服用也不會產生任何副作 用。 我們將以下列的實施例、試驗實施例和圖表進一步詳 細敘述本發明。 實施例1 配方 植物蠕蟲 100mg (依照天然藥物重4 沐若普(11111丨^01131118)3〇〇1112(依照天然藥物重量) Adkistrodon 2 5〇mg (依照天然藥物重量) 牛磺酸 500mg 人參 600 mg (依照天然藥物重量) 紫雲英 300mg (依照天然藥物重量) 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁}
Polygonati root 3 0 0 m g (依照天然藥物重量) 甘草根 150mg (依照天然藥物重量)
Poria sclerotiun 3 0 〇mg (依照天然藥物重量) 地黃根 200mg (依照天然藥物重4) 日本當歸根 200mg(依照天然藥物重量) 荔枝 200mg (依照天然藥物重 肉桂皮 15〇mg(依照天然藥物重毚彡 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) " ' —~ 一 9 - 504385 A7 B7 五、發明説明(7 ) 鹿茸角 不結果的麥芽汁 維生素B 2 維生素B 6 無水咖啡因 3 0 0mg (依照天然藥物重量) 1 0 0 Omg (依照天然藥物重量) g g 5 0 m g 將上述成份與適當量的檸檬酸鈉、蘋果酸、蔗糖、D 一山梨糖醇溶液、苯甲酸、聚氧乙烯氫化箆麻油和蒸餾水 混合,以製備成5 0 m p液體製劑。 實施例2 配方 植物蠕蟲 15 Omg (依照天然藥物重量) 沐若普(muirapuama)3 5 Omg (依照天然藥物重量) (請先閱讀背面之注意事項再填寫本頁) 、?τ 經濟部中央標準局員工消費合作社印製
Adk i stodon 牛磺酸 人參 紫雲英根 Po 1 ygonat i root 甘草 Poria sclerotium 地黃根 曰本當歸根 3 0 Omg (依照天然藥物重量) 5 0 0 m g 6 0 Omg (依照天然藥物重量) 3 0 Omg (依照天然藥物重量) 3 0 Omg (依照天然藥物重量) 15 Omg (依照天然藥物重量) 3 0 Omg (依照天然藥物重量) 2 0 Omg (依照天然藥物重量) 2 0 Omg (依照天然藥物重量) 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) ~ 10 - 504385 A7 B7 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁)
五、發明説明(8 ) 荔 枝 2 0 肉 桂 皮 1 5 鹿 茸 角 3 0 不 結 果 的 麥芽汁 10 0 維 生 素 B 2 5 m 維 生 素 B 6 5 m m 水 咖 啡 因 5 0 m 將上述成份與適當量的 一山梨糖醇溶液、苯甲酸、 混合,以製備成5 0 m j?液 實施例3 配方 植物蠕蟲 30 沐若普(muirapuama)3 0 Adkistodon 2 5 牛磺酸 50 人參 6 0 紫雲英根 30 甘草 10
Poria sclerotium 2 5 地黃根 30 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) g g g 檸檬酸鈉、蘋果酸、蔗糖、D 聚氧乙烯氫化箆麻油和蒸餾水 體製劑。 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) 0 m g 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) 〇mg (依照天然藥物重量) Omg (依照天然藥物重量) 〇mg (依照天然藥物重量) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -11 - 504385 經濟部中央標準局員工消費合作社印製 牛磺酸 人參 紫雲英根 A7 B7 五、發明説明(9 曰本當歸根 3 0 0 m g Cistanchi s caul is 3 0 0 m g 中國膠木膠 3 0 0 m g 內風消子 2 0 0 m g 肉桂皮 2 0 0 m g 鹿奪角 3 0 0 m g 不結果的麥芽汁 1 0 0 0 m g 維生素B 2 5 m g 維生素B 6 5 m g 無水咖啡因 5 0 m g 將上述成份與適當量的檸檬酸、檸檬酸鈉、蔗糖、D 一山梨糖醇溶液、苯甲酸、聚氧乙烯氫化油和蒸餾水混合 ,以製備成5 0 m j?液體製劑。 實施例4 配方 植物蠕蟲 330mg (依照天然藥物重量) 沐若普(muirapuama) 4 5 0 m g (依照天然藥物重量) Adkistrodon 4 0 〇mg (依照天然藥物重量) 5 0 0 m g 6 0 0mg (依照天然藥物重量) 3 0 0mg (依照天然藥物重量) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)
-12 - 504385 A7 B7 五、發明説明(10 )
甘草根 1 0 0 m g (依照天然藥物重量) Poria scerotium 2 5 0 m g (依照天然藥物重量) 地黃根 3 0 0 m g (.依照天然藥物重量) 曰本當歸根 3 0 0 m g (依照天然藥物重量) C i stanch i s caul is 3 0 0 m g (依照天然藥物重量) 中國膠木膠 3 0 0 m g (依照天然藥物重量) 內風消子 2 0 0 m g (依照天然藥物重量_) 肉桂皮 2 0 0 m g (依照天然藥物重量) 鹿奪角 3 0 0 m g (依照天然藥物重量) 不結果的麥芽汁 1 0 0 0 m g (依照天然藥物重量) 維生素B 2 5 m g 維生素B 6 5 m g 無水咖啡因 5 0 m S (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 將上述成份與適當量的檸檬酸鈉、蘋果酸、蔗糖、D -山梨糖醇溶液、苯甲酸、聚氧乙烯氫化油和蒸餾水混合 ,以製備成5 Omj?液體製劑。 實施例5 配方 植物蠕蟲 100mg (依照天然藥物重量) 沐若普(muirapuama) 3 0 0 m g (依照天然藥物重量) 地黃根 1500mg(依照天然藥物重量) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -13 - 504385 A7 B7 5 0 〇mg (依照天然藥物重量) 7 5 〇mg (依照天然藥物重量) 7 5 Omg (依照天然藥物重量) 2 5 0mg (依照天然藥物重量) 3 0 〇mg (依照天然藥物重量) 2 0 〇mg (依照天然藥物重量) 5 〇 〇mg (依照天然藥物重量) 7 5 Omg (依照天然藥物重量) 5 0 Gmg (依照天然藥物重量) 將上述成份與適當量的甘露醇、羥丙基纖維素、間石夕 酸鎂鋁酸鹽、阿斯巴甜和香料均勻混合,以製成三包裝的 顆粒。 實施例6 配方 經濟部中央標準局員工消費合作社印製 五、發明説明(11 ) 不結果的麥芽汁 Eleutherococc Polygonati root 鹿茸角 人參 治階草塊莖 內風消子 何首烏根 肉桂皮 (請先閱讀背面之注意事項再填寫本頁) 植物蠕蟲 300mg(依照天然藥物重量) 沐若普(muirapuama)3 0 Omg (依照天然藥物重量) 地黃根 lOOOmg(依照天然藥物重量)
Polygonat i root 5 0 0 m g (依照天然藥物重量) 鹿茸角 250mg(依照天然藥物重量) 人參 2000mg(依照天然藥物重量) 維生素B2 10mg 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 504385 A7 B7 5 m g i、發明説明(l2 維生素B 6 將上述成份與適當量的間矽酸鎂鋁酸鹽、聚水合6 0 和丙烯乙二醇均勻混合,然後填充至軟的膠囊而得到9顆 膠囊製劑。 實施例7 配方 植物蠕蟲 l〇〇mg (依照天然藥物重量) 沐若普(inuirapuama)2 0 0 m g (依照天然藥物重量) 不結果的麥芽汁 500mg (依照天然藥物重量) 鹿茸角 2〇〇mg (依照天然藥物重量) 人參 600mg (依照天然藥物重量) 何首烏根 300mg (依照天然藥物重量) 牛膽汁 650mg (依照天然藥物重量) (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 L -精胺酸氯化氫 d 1 —氯化肉鹼 維生素A 維生素B工 維生素B 2 維生素B 6 維生素B i 2 菸鹼酸醯胺 1 0 0 m g 5 0 m g 2 0 0 0 1 2 0 m g 1 5 m g 5 m g 1 0 m g 2 0 m g
U 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -15 - 504385 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(13) 泛酸縛 3 0 m g 維生素C 5 0 m g 維生素E 5 m g 將上述成份與適當量的碳酸氫鈉、聚乙烯吡咯酮、輕 無水矽酸、硬脂酸鎂、聚乙烯二醇、聚水合8 0和香料均 勻混合,以得到9顆錠劑。 試驗實施例1 將2 8隻平均體重爲2 0 0 g的雄性S D老鼠分成四 組,每組以口服方式服用相同體積的下列液體製劑,然後 老鼠進行強迫性游泳以決定其游泳的持久時間。 A組:服用本液體製劑(0 . 2 w / v %植物蠕蟲+ 0 . 6 w / v %沐若普(nuiirapiiama),以整體天然藥物 爲基準) B組:服用單一植物蠕蟲液體製劑(0 . 8 w / v % ) C組:服用單一沐若普(muirapuama)液體製劑( 0 8 w / v % ) D組:對照組(只含純水) A,B,C和D組的游泳持久時間的結果顯示於第1 圖。第1圖顯示老鼠分別服用本液體製劑(植物蠕蟲和沐 若普(muirapuama),單一植物蠕蟲液體製劑,單一沐若 普(m u i r a p u a m a )液體製劑和純水後,進行強迫性游泳, (請先閲讀背面之注意事項再填寫本頁) άτ
Hal IBIBi 1_ BUBi、一 一心 11_1 ι_ϋ··· §_1_1 11 —•f 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -16 - 504385 A7 B7 五、發明説明(14 ) 而得到的游泳持久時間結果。 從第1圖的結果我們發現,服用本液體製劑的A組, 其游泳持久時間明顯高於僅服用單一液體製劑的B和C組 〇 試驗實施例2 將平均體重爲2 0 0 g的雄性S D老鼠區分爲每組含 5隻老鼠的運動組和每組含7隻老鼠的非運動組。運動組 老鼠依照其體重每天給予其5 一 1 〇%重量負荷的強迫性 游泳3 0分鐘,進行1 〇天,並且依照下列液體製劑同時 實施二瓶選擇性試驗1 〇天,以決定其總攝取量。非運動 組老鼠也進行相同試驗,但不實施強迫性游泳。 A組:攝取本發明液體製劑(〇. 2w/v%植物蠕 蟲 +0 · 6w / v% 沐若普(muirapuama))。 / B組:攝取植物蠕蟲的單一液體製劑(〇. 8w/v % ) 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) C組:攝取沐若普(muirapuama)的單一液體製劑( 0 . 8 w / v % ) D組:對照組(只含純水) 運動組和非運動組的總攝取量結果顯示於第2圖。第 2圖顯示運動組和非運動組對於本發明液體製劑(植物蠕 蟲和)、植物蠕蟲的單一液體製劑、沐若普(muirapuaina )的單一液體製劑和對照組(純水)的總攝取量。
從第2圖結果可知,運動組中對於本發明液體製劑A 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 一 17 - 504385 A7 B7 五、發明説明(15 ) 的總攝取量與運動組對於單一液體製劑B和C相比,有明 顯增加。 (請先閲讀背面之注意事項再填寫本頁)
、1T
經濟部中央標準局員工消費合作社印製 ^«^0^W(CNS)A4«(21〇X _ _
Claims (1)
- A8B8C8D8 50,觀— ^ 丨,.本年月曰 89^ 12. I 4 六、申請專利範圍 附件(A) 第85115773號專利申請案 中文申請專利範圍修正本 民國89年12月修正 1 . 一種用於舒減生理及精神疲勞且改善虛弱身驅之 組成物,其係包含每一重量份植物懦蟲(plant worms) 之乙醇萃取物或乙醇流體萃取物的0. 002至500重 量份沐若普(muirapuama)之乙醇萃取物。 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 準 標 家 國 國 中 用 適 度 尺 張 紙 本 釐 公 97 一 2 X 10 (2 格 規 4 )A S)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34068095 | 1995-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW504385B true TW504385B (en) | 2002-10-01 |
Family
ID=18339289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW085115773A TW504385B (en) | 1995-12-27 | 1996-12-20 | Composition for relieving physical and mental fatigue and ameliorating weakened constitution |
Country Status (10)
Country | Link |
---|---|
US (1) | US6024984A (zh) |
EP (1) | EP0869806B1 (zh) |
KR (1) | KR19990076828A (zh) |
CN (1) | CN1081924C (zh) |
AT (1) | ATE207756T1 (zh) |
AU (1) | AU706059B2 (zh) |
CA (1) | CA2240257A1 (zh) |
DE (1) | DE69616591T2 (zh) |
TW (1) | TW504385B (zh) |
WO (1) | WO1997024134A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002308649A1 (en) * | 2001-05-04 | 2002-11-18 | Theralife, Inc. | Compositions and methods for enhancing drug delivery |
DE10214168A1 (de) * | 2002-03-27 | 2003-10-09 | Siegfried Irion | Coffeinhaltiges Getränkeerzeugnis |
US7790176B2 (en) * | 2007-06-01 | 2010-09-07 | Botanica Bioscience Corporation | Formula for improving physical performance and related methods |
US20090263514A1 (en) * | 2008-04-21 | 2009-10-22 | Govindan Gopinathan | Cold and flu tonic |
US20110229553A1 (en) * | 2010-01-22 | 2011-09-22 | Elaine Elisabetsky | Plant Extract with Pharmacological Profile for Treating or Preventing Diseases, Dysfunctions and Disorders of the Central Nervous System, Neurodegenerative Disorders and Sequel from Vascular Dementia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4584293A (en) * | 1992-07-20 | 1994-02-14 | Taisho Pharmaceutical Co., Ltd. | Tonic |
CN1099992A (zh) * | 1994-06-24 | 1995-03-15 | 爱新觉罗松石 | 养生茶 |
CN1098264A (zh) * | 1994-10-17 | 1995-02-08 | 凌青 | 一种养生液 |
WO1996016956A1 (fr) * | 1994-12-02 | 1996-06-06 | Kao Corporation | Derives de flavanonol et composition contenant ces derives propre a nourrir les cheveux et a stimuler leur croissance |
-
1996
- 1996-12-20 CN CN96199360A patent/CN1081924C/zh not_active Expired - Fee Related
- 1996-12-20 EP EP96942599A patent/EP0869806B1/en not_active Expired - Lifetime
- 1996-12-20 US US09/077,869 patent/US6024984A/en not_active Expired - Fee Related
- 1996-12-20 AT AT96942599T patent/ATE207756T1/de not_active IP Right Cessation
- 1996-12-20 KR KR1019980704954A patent/KR19990076828A/ko not_active Application Discontinuation
- 1996-12-20 TW TW085115773A patent/TW504385B/zh active
- 1996-12-20 AU AU11722/97A patent/AU706059B2/en not_active Ceased
- 1996-12-20 CA CA002240257A patent/CA2240257A1/en not_active Abandoned
- 1996-12-20 WO PCT/JP1996/003733 patent/WO1997024134A1/en not_active Application Discontinuation
- 1996-12-20 DE DE69616591T patent/DE69616591T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6024984A (en) | 2000-02-15 |
CN1081924C (zh) | 2002-04-03 |
EP0869806B1 (en) | 2001-10-31 |
DE69616591T2 (de) | 2002-09-05 |
AU706059B2 (en) | 1999-06-10 |
DE69616591D1 (de) | 2001-12-06 |
ATE207756T1 (de) | 2001-11-15 |
AU1172297A (en) | 1997-07-28 |
CN1206349A (zh) | 1999-01-27 |
CA2240257A1 (en) | 1997-07-10 |
WO1997024134A1 (en) | 1997-07-10 |
EP0869806A1 (en) | 1998-10-14 |
KR19990076828A (ko) | 1999-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hajimonfarednejad et al. | Cinnamon: A systematic review of adverse events | |
US20060159784A1 (en) | Polyherbal compositions and methods for treating viral infections | |
TW200843726A (en) | Agent for relief or prevention of xerostomia | |
KR20020041639A (ko) | 천연 생약제 추출물을 포함하는 숙취해소용 조성물 및이를 유효성분으로 함유하는 건강보조식품 | |
CN106975069A (zh) | 一种保肝护肝组合物及其制备方法 | |
JP2013209354A (ja) | 認知機能低下改善用組成物 | |
TW474815B (en) | A process for preparing the galenic composition for prophylaxis and treatment of after effects due to excessive alcohol intake | |
JP2002275086A (ja) | 虚弱体質改善用組成物 | |
TW504385B (en) | Composition for relieving physical and mental fatigue and ameliorating weakened constitution | |
CN103251698A (zh) | 一种具有解酒保肝护胃功效的葛根饮液及其制法 | |
KR100504351B1 (ko) | 식물 추출물을 함유하는 숙취해소용 식품 조성물 | |
CN101524492A (zh) | 一种具有增强免疫力功能的中药口服制剂及其制备方法 | |
EP1520584A1 (en) | Composition for the activation of the immune system | |
KR101808944B1 (ko) | 생강 추출물의 비극성 용매 분획물을 유효성분으로 포함하는 월경통 및 조기분만진통의 예방 및 치료용 약학적 조성물 | |
RU2393721C2 (ru) | Средство и безалкогольный напиток для профилактики последствий и уменьшения проявлений острой алкогольной интоксикации | |
KR101992174B1 (ko) | 복합 한방약초를 포함하는 숙취 예방, 숙취 해소 및 간 보호용 정제형 조성물 및 그 제조방법 | |
Ravi et al. | Beneficial Effects of Medicinal Plants Used For the Management of Obesity-A Review | |
CN112716840A (zh) | 一种抑制幽门螺旋杆菌组合物及其制备方法及用途 | |
KR100488511B1 (ko) | 생약재를 이용한 건강보조식품 및 그 조성물 | |
JP7451124B2 (ja) | 内服組成物およびその吸湿抑制方法 | |
CN106580770A (zh) | 一种美齿防护牙膏 | |
RU2414828C2 (ru) | Состав для активизации иммунной системы | |
JP2010018525A (ja) | 口臭、体臭及び糞尿臭改善剤 | |
EP1702615A1 (en) | Glucose tolerance-improving agent | |
JP2022052797A (ja) | 血中酸素濃度改善剤 |